Oslo University Hospital research seminar Monday May 9th

Discovery of biologically active small molecular compounds

Welcome to the next Oslo University Hospital (OUH) research seminar entitled
"Discovery of biologically active small molecular compounds"

Time: Monday, May 9th, 2016, at 14:30 – 16:10.
Place: Red Auditorium, Rikshospitalet, Sognsvannsveien 20, Oslo.

Speakers: Kjetil Taskén, Phil Gribbon, Anne Jorunn Stokke, Jarl Underhaug, Jeanette H. Andersen, Geir Klinkenberg and Lina Prasmickaite

NOR-Openscreen is the Norwegian node of the EU-Openscreen infrastructure project. We support the discovery of biologically active substances in all areas of the Life Sciences by providing transnational, open access to the most advanced technologies, chemical and biological resources as well as expertise through Europe (For more information: http://openscreen.no/).

This meeting is to present the capabilities of EU-Openscreen and NOR-Openscreen and to illustrate the impact of screening activities on research projects.

Coffee and food will be served from 14:15

Program:

Introduction and Presentation of EU-Openscreen

Chair: Kjetil Taskén, Biotechnology Centre of Oslo/NCMM

14:30 Welcome
Kjetil Taskén

14:35 EU-OPENSCREEN - Europe's new infrastructure for Chemical Biology - What we do and how to access our services
Phil Gribbon, CEO, EU-Openscreen, Leibniz-Institut für Molekulare Pharmakologie, Berlin.

Presentation of the national infrastructure NOR-Openscreen

14:55 Oslo node: Target- and phenotypic based high throughput screening
Anne Jorunn Stokka, Chemical Biology Platform, Biotechnology Centre of Oslo.

15:05 Bergen node: Biophysical methods for compound screening
Jarl Underhaug, Manager of the Norwegian NMR Platform, Dept. of Chemistry, University of Bergen.

15:15 Tromsø node: Bioactivity screening and identification of compounds from Arctic marine organism
Jeanette H. Andersen, Marbio, The Arctic University of Norway.

15:25 Trondheim/SINTEF node: Biotechnology and HTS at SINTEF Materials and Chemistry
Geir Klinkenberg, SINTEF Materials and Chemistry, Trondheim.

User presentation

15:40 Is stroma to blame for resistance to targeted therapy? in search of novel drug combinations for melanoma
Lina Prasmickaite, Institute for Cancer Research, The Norwegian Radium Hospital.

16:00 Closing remarks

Everybody is welcome!

On behalf of the organizing committee for OUH research seminars,

Alexandre Corthay (committee leader)


On behalf of the organizing committee for OUH research seminars,

Alexandre Corthay (committee leader)